Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Advanced Solid Tumor
×
pembrolizumab
×
Clear all
Filters
3
NCT02553499
2019-11-04
MK-1248-001
Merck Sharp & Dohme LLC
Phase 1
Terminated
37 enrolled
26 charts